A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

The major conformational IgE-binding epitopes of hevein (Hev b6.02) are identified by a novel chimera-based allergen epitope mapping strategy




TekijätKarisola P, Alenius H, Mikkola J, Kalkkinen N, Helin J, Pentikainen OT, Repo S, Reunala T, Turjanmaa K, Johnson MS, Palosuo T, Kulomaa MS

KustantajaAMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC

Julkaisuvuosi2002

JournalJournal of Biological Chemistry

Tietokannassa oleva lehden nimiJOURNAL OF BIOLOGICAL CHEMISTRY

Lehden akronyymiJ BIOL CHEM

Vuosikerta277

Numero25

Aloitussivu22656

Lopetussivu22661

Sivujen määrä6

ISSN0021-9258

DOIhttps://doi.org/10.1074/jbc.M201076200


Tiivistelmä
A novel approach to localize and reconstruct conformational IgE-binding epitope regions of hevein (Hev b6.02), a major natural rubber latex allergen, is described. An antimicrobial protein (AMP) from the amaranth Amaranthus caudatus was used as an immunologically non-IgE-binding adaptor molecule to which terminal or central parts of hevein were fused. Hevein and AMP share a structurally identical core region but have different N-terminal and C-terminal regions. Only 1 of 16 hevein-allergic patients showed weak IgE binding to purified native or recombinant AMP. Chimeric AMP with the hevein N terminus was recognized by IgE from 14 (88%) patients, and chimeric AMP with the hevein C terminus was recognized by IgE from 6 (38%) patients. In contrast, chimeric AMP containing the hevein core region was recognized by IgE from only two patients. When both the N-terminal and C-terminal regions of hevein were fused with the AMP core, IgE from all 16 patients bound to the chimera. This chimera was also able to significantly inhibit (>70%) IgE binding to the native hevein. On the contrary, linear synthetic peptides corresponding to hevein regions in the AMP chimeras showed no significant IgE binding capacity in either enzyme-linked immunosorbent assay or inhibition enzyme-linked immunosorbent assay. These results suggest that the IgE binding ability of hevein is essentially determined by its N-terminal and C-terminal regions and that major IgE-binding epitopes of hevein are conformational. The chimera-based epitope mapping strategy described here provides a valuable tool for defining structural epitopes and creating specific reagents for allergen immunotherapy.



Last updated on 2024-26-11 at 22:32